Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC Injection for Perianal Crohn's Disease Fistulas
NCT03056664Phase 3Unknown
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- Jan 2017
- Primary completion
- Dec 2019
- Modality
- Stem Cell Therapies
01
Overview
Phase 3, randomised, double-blind trial of mesenchymal stem cells in Crohn's disease and perianal fistula (3 arms), sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Primary endpoint: Clinical response (fistula closure) at 12 weeks. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
Crohn's diseaseperianal fistula
Beyond the preview
Go deeper on NCT03056664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03056664.